Autologous mononuclear cells
21-000088
Phase 1 mab active
Quick answer
Autologous mononuclear cells for Congenital Heart Disease, SRV Dependent is a Phase 1 program (mab) at Regen BioPharma Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regen BioPharma Inc
- Indication
- Congenital Heart Disease, SRV Dependent
- Phase
- Phase 1
- Modality
- mab
- Status
- active